Abstract

Benzodiazepine use is associated with adverse drug events and higher mortality. Known risk factors for benzodiazepine-related adverse events include lung disease, substance use, and vulnerability to fracture. To determine whether benzodiazepine prescribing is associated with risk factors for adverse outcomes. Longitudinal cohort study between July 1, 2011, and June 30, 2012. Patients who visited hospital- and community-based practices in a primary care practice-based research network. Odds ratio of having a target medical diagnosis for patients who received standard and high-dose benzodiazepine prescriptions; rates per 100 patients for outpatient and emergency department visits and hospitalizations. Among 65,912 patients, clinicians prescribed at least one benzodiazepine to 15% (9821). Of benzodiazepine recipients, 5% received high doses. Compared to non-recipients, benzodiazepine recipients were more likely to have diagnoses of depression (OR, 2.7; 95% CI, 2.6-2.9), substance abuse (OR, 2.2; 95% CI, 1.9-2.5), tobacco use (OR, 1.7; 95% CI, 1.5-1.8), osteoporosis (OR, 1.6; 95% CI, 1.5-1.7), chronic obstructive pulmonary disease (OR, 1.6; 95% CI, 1.5-1.7), alcohol abuse (OR, 1.5; 95% CI, 1.3-1.7), sleep apnea (OR, 1.5; 95% CI, 1.3-1.6), and asthma (OR, 1.5; 95% CI, 1.4-1.5). Compared to low-dose benzodiazepine recipients, high-dose benzodiazepine recipients were even more likely to have certain medical diagnoses: substance abuse (OR, 7.5; 95% CI, 5.5-10.1), alcohol abuse (OR, 3.2; 95% CI, 2.2-4.5), tobacco use (OR, 2.7; 95% CI, 2.1-3.5), and chronic obstructive pulmonary disease (OR, 1.5; 95% CI, 1.2-1.9). Benzodiazepine recipients had more primary care visits per 100 patients (408 vs. 323), specialist outpatient visits (815 vs. 578), emergency department visits (47 vs. 29), and hospitalizations (26 vs. 15; p < .001 for all comparisons). Clinicians prescribed benzodiazepines and high-dose benzodiazepines more frequently to patients at higher risk for benzodiazepine-related adverse events. Benzodiazepine prescribing was associated with increased healthcare utilization.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.